BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation
Cell Reports Medicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation. // Cell Reports Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005902?dgcid=rss_sd_all
BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation. Cell Reports Medicine. https://www.sciencedirect.com/science/article/pii/S2666379126005902?dgcid=rss_sd_all
“BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation.” Cell Reports Medicine.
@article{article107248,
title = {BT-115386, a MAT2A inhibitor, targets MTAP-deficient nasopharyngeal carcinoma via c-Myc and p53 modulation},
journal = {Cell Reports Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005902?dgcid=rss_sd_all}
}